CRYO-CELL INTERNATIONAL, INC. (CCEL) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2019-05-31..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2019-05-31..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2019-05-31..
Borrowing debt
Overview →Financial period ending 2019-05-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2019-05-31. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2019-05-31. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2019-05-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | (m) | |
| Borrowing debt due after one year | 1.43M USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | 7.31M USD | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current |
| Borrowing debt | (m) | Long-term Debt, Excluding Current Maturities |
| Total assets | 40.89M USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2019-05-31 | (m) | (m) | (m) | $1.43M | (m) | $7.31M | $40.89M | (m) |
| 2019-02-28 | (m) | (m) | (m) | $1.43M | (m) | $7.88M | $43.34M | (m) |
| 2018-11-30 | (m) | (m) | (m) | $1.43M | (m) | $6.92M | $42.39M | (m) |
| 2018-08-31 | (m) | (m) | (m) | $1.43M | (m) | $7.99M | $42.65M | (m) |
| 2018-05-31 | (m) | (m) | (m) | $1.43M | (m) | $7.11M | $22.22M | (m) |
| 2018-02-28 | (m) | (m) | (m) | $1.43M | (m) | $7.58M | $21.91M | (m) |
| 2017-11-30 | (m) | (m) | (m) | $1.43M | (m) | $6.72M | $23.91M | (m) |
| 2017-08-31 | (m) | (m) | (m) | $1.43M | (m) | $5.19M | $21.32M | (m) |
| 2017-05-31 | (m) | (m) | (m) | $1.43M | (m) | $5.18M | $21.04M | (m) |
| 2017-02-28 | (m) | (m) | (m) | $1.43M | (m) | $3.98M | $19.75M | (m) |
| 2016-11-30 | (m) | (m) | (m) | $1.43M | (m) | $4.12M | $19.54M | (m) |
| 2016-08-31 | (m) | (m) | (m) | $1.43M | (m) | $2.66M | $17.54M | (m) |
| 2016-05-31 | (m) | (m) | (m) | $2.30M | (m) | $5.19M | $20.47M | (m) |
| 2016-02-29 | (m) | (m) | (m) | $2.30M | (m) | $4.20M | $19.10M | (m) |
| 2015-11-30 | (m) | (m) | (m) | $2.30M | (m) | $4.76M | $19.50M | (m) |
| 2015-08-31 | (m) | (m) | (m) | $2.30M | (m) | $3.18M | $19.44M | (m) |
| 2015-05-31 | (m) | (m) | (m) | $2.30M | (m) | $4.45M | $10.94M | (m) |
| 2015-02-28 | (m) | (m) | (m) | $2.30M | (m) | $3.65M | $10.52M | (m) |
| 2014-11-30 | (m) | (m) | (m) | $2.30M | (m) | $3.38M | $10.21M | (m) |
| 2014-08-31 | (m) | (m) | (m) | $2.30M | (m) | $3.57M | $10.11M | (m) |
| 2014-05-31 | (m) | (m) | (m) | $2.30M | (m) | $3.54M | $10.27M | (m) |
| 2014-02-28 | (m) | (m) | (m) | $2.30M | (m) | (m) | $10.47M | (m) |
| 2013-11-30 | (m) | (m) | (m) | $2.30M | (m) | (m) | $11.50M | (m) |
| 2013-08-31 | (m) | (m) | (m) | $2.30M | (m) | (m) | $11.37M | (m) |
| 2013-05-31 | (m) | (m) | (m) | $2.30M | (m) | (m) | $11.94M | (m) |
| 2013-02-28 | (m) | (m) | (m) | $2.30M | (m) | (m) | $12.18M | (m) |
| 2012-11-30 | (m) | (m) | (m) | $2.30M | (m) | (m) | $12.33M | (m) |
| 2012-08-31 | (m) | (m) | (m) | $2.30M | (m) | (m) | $12.70M | (m) |
| 2012-05-31 | (m) | (m) | (m) | $2.65M | (m) | (m) | $13.13M | (m) |
| 2012-02-29 | (m) | (m) | (m) | $2.85M | (m) | (m) | $16.49M | (m) |
| 2011-11-30 | (m) | (m) | (m) | $2.85M | (m) | $7.31M | $19.47M | (m) |
| 2011-08-31 | (m) | (m) | (m) | $3.75M | (m) | $6.88M | $18.59M | (m) |
| 2010-11-30 | (m) | (m) | (m) | $3.75M | (m) | $9.50M | $18.16M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |